Physician profile
Ashraf S Youssef
NPI 1629249818
$95,463.99
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,705 · 2020: $3,236 · 2021: $21K · 2022: $22K · 2023: $27K · 2024: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $31K · Royalty Or License: $7,180 · Travel and Lodging: $3,746 · Food and Beverage: $1,811 · Entertainment: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $31,075.00 |
| Royalty Or License | $7,180.02 |
| Travel and Lodging | $3,746.37 |
| Food and Beverage | $1,811.06 |
| Entertainment | $120.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $75,868.82 | 2019-2024 | Core, Sonopet Iq, Spetzler-Malis |
| Mizuho America, INC. | $18,011.67 | 2019-2024 | |
| Zimmer Biomet Holdings, INC. | $662.77 | 2019-2023 | Neuro Plating System |
| Nsk America Corporation | $425.05 | 2019-2023 | |
| Abbott Laboratories | $319.98 | 2022 | |
| Integra Lifesciences Corporation | $97.22 | 2023 | Integra, Integra Duo, Instruments-Orthopedic |
| Medtronic, INC. | $45.32 | 2022 | |
| Allergan, INC. | $23.49 | 2020 | |
| Brainlab, INC. | $9.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashraf Youssef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.